Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,961 | 1,093 | 99.8% |
| Education | $24.05 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,152 | 207 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,441 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,121 | 50 | $0 (2024) |
| ABBVIE INC. | $1,110 | 82 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,075 | 97 | $0 (2024) |
| Amgen Inc. | $942.90 | 57 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $911.62 | 65 | $0 (2022) |
| Daiichi Sankyo Inc. | $754.77 | 33 | $0 (2021) |
| Lilly USA, LLC | $696.92 | 59 | $0 (2024) |
| Merck Sharp & Dohme LLC | $589.48 | 54 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,320 | 68 | ABBVIE INC. ($267.99) |
| 2023 | $1,471 | 120 | ABBVIE INC. ($338.38) |
| 2022 | $1,826 | 124 | Novo Nordisk Inc ($399.39) |
| 2021 | $1,425 | 95 | Novo Nordisk Inc ($480.29) |
| 2020 | $2,122 | 146 | Novo Nordisk Inc ($482.82) |
| 2019 | $2,654 | 171 | Amgen Inc. ($423.98) |
| 2018 | $2,590 | 181 | Novo Nordisk Inc ($270.89) |
| 2017 | $2,577 | 193 | Daiichi Sankyo Inc. ($458.99) |
All Payment Transactions
1,098 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Endocrinology | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Biological | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 10/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Biological | ||||||
| 10/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), Akreos AO Micro Incision Lens | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Gastroenterology | ||||||
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Biological | ||||||
| 08/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 08/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,303 | 4,287 | $445,322 | $145,472 |
| 2022 | 22 | 1,436 | 2,820 | $428,274 | $153,781 |
| 2021 | 23 | 1,334 | 1,875 | $305,731 | $107,500 |
| 2020 | 16 | 1,235 | 1,757 | $304,160 | $91,621 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 298 | 588 | $123,448 | $32,843 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 261 | 261 | $80,974 | $32,305 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 280 | $85,205 | $24,108 | 28.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 55 | 55 | $23,425 | $15,331 | 65.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 60 | 327 | $45,731 | $14,369 | 31.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 36 | 36 | $14,675 | $5,745 | 39.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 129 | $16,645 | $4,465 | 26.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $4,277 | $3,377 | 79.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 24 | 73 | $8,919 | $2,497 | 28.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $7,014 | $2,202 | 31.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $7,250 | $1,729 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $3,216 | $1,431 | 44.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 36 | $3,934 | $1,280 | 32.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 145 | $5,633 | $1,246 | 22.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 20 | 31 | $4,094 | $1,187 | 29.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 19 | $2,462 | $634.03 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 27 | $1,484 | $266.64 | 18.0% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2023 | 19 | 1,900 | $1,900 | $212.88 | 11.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 184 | $4,600 | $143.73 | 3.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 29 | $435.00 | $98.89 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 297 | 658 | $119,756 | $38,613 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 257 | 257 | $75,044 | $32,606 | 43.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 87 | 527 | $54,281 | $23,855 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 265 | $71,020 | $22,323 | 31.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 33 | 164 | $25,912 | $6,719 | 25.9% |
About Dr. Mark Lonquist, MD
Dr. Mark Lonquist, MD is a Family Medicine healthcare provider based in Goodyear, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629064613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lonquist, MD has received a total of $15,985 in payments from pharmaceutical and medical device companies, with $1,320 received in 2024. These payments were reported across 1,098 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($15,961).
As a Medicare-enrolled provider, Lonquist has provided services to 5,308 Medicare beneficiaries, totaling 10,739 services with total Medicare billing of $498,374. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goodyear, AZ
- Active Since 09/23/2005
- Last Updated 04/18/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629064613
Products in Payments
- Ozempic (Drug) $1,056
- JARDIANCE (Drug) $735.97
- TRELEGY ELLIPTA (Drug) $697.71
- INVOKANA (Drug) $450.08
- XARELTO (Drug) $435.42
- UBRELVY (Drug) $409.29
- FARXIGA (Drug) $397.92
- JANUVIA (Drug) $365.74
- Movantik (Drug) $338.47
- QULIPTA (Drug) $335.45
- Aimovig (Biological) $324.71
- Vascepa (Drug) $308.04
- INJECTAFER (Drug) $300.16
- TRULICITY (Drug) $291.35
- STIOLTO RESPIMAT (Drug) $263.44
- Victoza (Drug) $262.88
- Rybelsus (Drug) $262.87
- Prolia (Biological) $262.63
- Trintellix (Drug) $245.59
- XIFAXAN (Drug) $223.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goodyear
Dr. John Monroe, M.d, M.D
Family Medicine — Payments: $13,491
Dr. Darrin Scherer, D.o, D.O
Family Medicine — Payments: $4,006
Tricia Stytle, D.o, D.O
Family Medicine — Payments: $4,003
Dr. Natalie Lake, Md, MD
Family Medicine — Payments: $3,472
Dr. Nathan Tholl, M.d, M.D
Family Medicine — Payments: $2,157
Dr. David Jensen, D.o, D.O
Family Medicine — Payments: $1,735